-transparent.png){kind=logo}
A woman aged 70 years developed reversible renal involvement during intravenous treatment with acyclovir. In order to prevent renal involvement during treatment with acyclovir, the following precautions are recommended: acyclovir should be infused slowly, regular control of renal function should be undertaken and the dosage should be reduced if evidence of renal involvement is found.
Related Publications
K Bömers, and
K Gedebjerg
November 1981,
Lancet (London, England),
K Bömers, and
K Gedebjerg
January 1988,
American journal of nephrology,
K Bömers, and
K Gedebjerg
April 1989,
Anales de medicina interna (Madrid, Spain : 1984),
K Bömers, and
K Gedebjerg
July 1982,
The American journal of medicine,
K Bömers, and
K Gedebjerg
July 1988,
The Laryngoscope,
K Bömers, and
K Gedebjerg
July 2004,
Revue neurologique,
K Bömers, and
K Gedebjerg
October 2006,
Journal of the European Academy of Dermatology and Venereology : JEADV,
K Bömers, and
K Gedebjerg
January 2005,
Revista da Associacao Medica Brasileira (1992),
K Bömers, and
K Gedebjerg
April 2022,
Mikrobiyoloji bulteni,
K Bömers, and
K Gedebjerg
March 1982,
Lancet (London, England),
